Dow Up 0.08% Nasdaq Down 0.30%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.21 Up 0.01(0.83%) Sep 19, 4:00PM EDT
|After Hours : 1.21 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:1.20
Open:1.20
Bid:1.21 x 500
Ask:1.24 x 6500
1y Target Est:3.10
Beta:2.28
Next Earnings Date:N/A
Day's Range:1.20 - 1.22
52wk Range:1.14 - 5.19
Volume:994,388
Avg Vol (3m):2,247,650
Market Cap:170.66M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ZGNX

Comparison

Symbol% ChgMkt Cap
ZGNXUp 0.83%170.66M
AZNUp 0.76%94.37B
GSKUp 0.19%113.81B
PFEDown 0.59%192.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback